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The gamma evaluation method as a routine 
QA procedure of IMRT
Janusz WINIECKI, Tomasz MORGAŚ, Karolina MAJEWSKA, 
Barbara DRZEWIECKA
ABSTRACT
BACKGROUND: The conventional QA procedures dedicated to 3D CRT are unsatisfactory if the dMLC is 
in operation. In the case of IMRT not only should the dose on the beam axis, but also its distribution 
in the total plane perpendicular to the beam be taken under control. The comparison between the 
predicted and the observed fl uence can be achieved using the gamma method. It takes into consider-
ation the dose difference and the spatial displacement between analyzed points to provide a g-index 
as a result of comparison. 
AIM: The aim of the investigation was to develop the procedure of IMRT verifi cation based on the 
gamma algorithm.
MATERIALS AND METHODS: 700 patients have been irradiated using IMRT since 2002. Over 1500 im-
ages recorded on the fi lm and/or EPID have been analyzed with the help of self-made software. His-
tograms of g-value and the g- images have been created for each fi eld. The fi elds have been classifi ed 
depending on tumour location and the method of dose delivery, to obtain an average result for each 
class. We have performed a comparison of g-histograms acquired with the help of different methods 
of recording.
RESULTS: We have observed a correlation between results of verifi cation obtained with the help of the 
gamma algorithm and the method of intensity modulation.
CONCLUSION: Gamma evaluation allows one to fi nd local hot-spots caused by irregularities in leaf 
motion or the tongue-and-groove effect.
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BACKGROUND
The concept of IMRT is an intentional diver-
sifi cation of dose distribution for the purpose 
of the best irradiation of the tumour body and 
simultaneous protection of the organs at risk 
[1]. The front of the IMRT beam in contrast 
with 3D CRT can be strongly undulated and 
the traditional QA procedures are not able to 
monitor the dose in the total plane perpendicu-
lar to the beam axis. There are several circum-
stances having an effect on the point dose re-
ally absorbed by tissue. The most important is 
the dynamic mode of MLC, which is required 
for dose diversifi cation and pre-planned for 
intensity modulation. Of course, we cannot 
predict random failures and accidents which 
have great weight in the difference between 
expected and acquired dose. However, from 
time to time there are occurrences which are 
undesired but repetitive and infl uence the local 
dose accumulated by the absorbent. They take 
place during proper execution of the treatment 
plan, as has been carefully discussed by Ping 
Xia and Lynn J. Verhey [2].
The irradiation leakage through a slit be-
tween adjacent leaves can be only statistically 
taken into account, which may be done by a 
treatment planning system (TPS). We can
observe straight lines with high dose (hot-
spots), whose escalation depends on the time 
of exposure. In order to reduce the dose leak-
age the border between leaves is in fact not a 
straight line [2].
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Figure 1 presents the cross-section of the 
MLC and the intensity profi le perpendicular 
to the direction of leaf motion. If the velocity 
of the two next leaves is very different, one 
can observe the “tongue and groove” effect. 
It occurs if signifi cant dose gradients perpen-
dicular to the leaf direction are expected. An 
example of this situation is presented in Fig. 2: 
the narrow region (white line) with dose much 
below the expected value. In the isocentre 
plane they are about 1 mm wide. Functional 
motions of irradiated tissues and ineffective-
ness of patient immobilization usually reduce 
this undesired effect if the treatment consists 
of many fractions and the plan contains multi-
ple gantry positions [3]. However, it is diffi cult 
to answer the question: Is the acquired dose 
distribution always really acceptable in the 
case of proper realization of the IMRT plan?
There have been several methods of IMRT 
verifi cation proposed and strongly recom-
mended in previous publications [4, 5, 6 ,7]. 
The investigators suggest detailed control 
of the IMRT plans, comparison of optimal 
distributions obtained by TPS and different 
methods of calculation. Chui et al. [8] pres-
ent some useful tests which help to keep the 
MLC in a good condition, which is the key to 
proper IMRT execution. On the basis of the 
above-mentioned papers of Depuydt et al. [5] 
and Low et. al [7] we have developed our own 
procedure for clinical dosimetry of IMRT 
treatment. It takes advantage of the gamma 
evaluation method to compare predicted dose 
distributions with images recorded on the 
treatment unit.
AIM
The aim of the investigation was to develop an 
independent procedure of IMRT verifi cation 
which would be performed on each treatment 
unit regardless of whether portal dosimetry 
is available or not. The procedure should be 
based on gamma algorithm and be viable in a 
clinical environment.
MATERIALS AND METHODS
In many radiotherapy departments the pre-
dicted dose distribution and the acquired one 
are compared using the gamma evaluation 
method. As a result of analysis the matrix of 
γ(rc) is obtained. For each reference point  
with respect to all measurement points rm the 
series of γ(rc, rm) , values is calculated using
formula (1):
(1)
where:
 rc, rm – distance between analyzed points,
D(rm)-D(rc) – dose difference,
DTA, DD – scaling factors equal to 3 mm 
and 3.3% respectively.
As a fi nal result γ(rc) the minimum of 
γ(rc, rm) , is chosen for each rc .
In our cancer centre IMRT was started in 
2002. In the beginning treatment plans were 
prepared using CadPlan/Helios, and recently 
Eclipse (Varian Medical Systems Inc, Palo 
Alto, CA). Varian Clinac 2300CD and 23Ex 
linear accelerators with Mark II 80MLC and 
Fig. 1. The irradiation leakage through a slit between adjacent 
leaves of the collimator. a) the crosssection of the MLC (hn0 – 
incident radiation, hnt – transmitted radiation), b) intensity profi le 
perpendicular to the MLC direction
Fig. 2. The tongue-and-groove effect: a) dose distribution re-
corded on the fi lm, b) corresponding g-image
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Millennium 80MLC collimators were used for 
treatments.
The fi rst step of the verifi cation procedure 
(the verifi cation mechanism is shown in Fig. 4) 
is to irradiate the solid water phantom (RW3, 
PTW Freiburg) with a dosimetric fi lm inserted 
(X-Omat V, Kodak). For simplicity, the gantry 
and collimator rotation are set to be zero. How-
ever, the number of MUs and the leaf position 
sequence are imported from the original treat-
ment plan. The source-to-fi lm distance is equal 
to 100 cm and the beam axis is perpendicular to 
the surface of the phantom. The fi lm is placed 
at a depth equivalent to 5 g/cm2 in the plane 
parallel to the phantom surface. Depending on 
the fi lm dosimetric characteristics (the most 
linear dependence between the optical density 
and the dose for XOmat V is between 20 cGy 
and 80 cGy, the dose variations outside this 
range are diffi cult to perceive) it is sometimes 
necessary to decrease the number of MUs. One 
fi lm for each therapeutic fi eld is irradiated and 
then developed in a semi-automatic developer 
(AX300 SE Alphatek Corporation Inc., Broad-
view, Il). The developed fi lms (VXR-12 plus, 
VIDAR Corporation) are digitized (Mephysto 
MC2, PTW Freiburg).
The specifi cation of the therapeutic fi eld 
border is diffi cult in the case of intensity 
modulation. The fi eld aperture is typically de-
fi ned as a 2D matrix of points accumulating 
no less than 50% of the maximal dose in the 
plane perpendicular to the beam axis. In the 
case of IMRT technique this approach could 
entail the loss of information about part of the 
fi eld, especially if the modulation of intensity 
is great. We decided to reduce the criterion 
down to 20 percent (compare Fig. 5). Areas 
with dose below 20% situated inside the con-
tour are understood as integral parts of the 
fi eld, similarly to shielded space in the case of 
standard radiotherapy.
The comparison of the dose plane measured 
on the treatment unit to the predicted dose 
distribution is performed on self-made soft-
ware GammaEval (BORLAND Delphi) based 
on a gamma algorithm. Distance-to-agree-
ment (DTA) and acceptable dose deviation 
(DD) are set to 3 mm and 3.3% of the local ref-
erence dose respectively. In accordance with 
equation (1) calculations are performed for 
each reference point rc successively with re-
Fig. 3. The concept of gamma verifi cation [5]: x, y, D – spatial 
and dose dimensions; DTA – distance-to-agreement; Dmax – max 
dose deviation; Dr, DD – local spatial and dose divergence of the 
analyzed point
Fig. 4. The verifi cation procedure: a) predicted dose image (fi lm/
portal) – treatment planning system, b) fi lm/portal exposure – 
treatment unit, c) gamma calculations – home-made software
Fig. 5. The infl uence of border-dose parameter on the fi eld area: 
a) 40% of max. dose, b) 20% of max. dose
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spect to all rm and rc passes an examination 
when γ(rc) = min γ(rc, rm)  ≤ 1. In theory calcu-
lations should be performed for all rm but in 
practice we believe that every measurement 
point at a distance greater than 3 x DTA from 
rc can be passed over.
As a result of comparison we obtain a 
coloured g-image which is a visualization of the 
2D matrix of γ(rc) . The fusion of the image and 
the corresponding DRR helps to recognize and 
localize irregularities of dose accumulated by 
the target and organs at risk. However, the 
quantitative estimation of fi eld irradiation is 
possible by courtesy of g-histograms which 
combine information about the g-index value 
(the quality of irradiation) with the area of the 
corresponding part of the fi eld (see Fig. 6).
The alternative method of IMRT verifi ca-
tion is portal dosimetry. Only the a-Si portal 
imagers are supported by portal dosimetry. 
The calibration procedure of our detectors 
has been performed according to the manu-
facturer’s instructions: the dependence of 
fi eld size on the signal intensity as well as 
beam diagonal profi le have been measured. 
All the measurements have been done at 105 
cm source-to-detector distance (SDD), as was 
suggested. Using the electronic portal image 
device (EPID) we are not able to exactly mea-
sure the dose distribution, which is the most 
important difference between the described 
method and fi lm dosimetry. However, the 
quantitative parameter of the detected signal 
has been defi ned. Its value is set to be 0.907 
CU (calibration units), while 100 MUs of pho-
ton, 10 cm x 10 cm fi eld size beam is generated 
and the SDD is set as mentioned above.
The QA of IMRT treatment begins with 
verifi cation plan preparation and predicted 
portal images calculation, which is performed 
with the help of the TPS. Before the exposure, 
the EPID was zeroed, and the dark fi eld and 
fl ood fi eld were measured.
We have a possibility to perform the eval-
uation of acquired images with the help of 
portal dosimetry software integrated in TPS 
as well as to compare the signal recorded by 
the imager with a predicted image using our 
home-made software. In contrast to commer-
cial software we obtain not only the 2D matrix 
of g-index values, but also differential and cu-
mulative histograms of g-value.
Before our software was implemented into 
clinical practice, several tests of its propriety 
were performed. The concept of GammaEval 
software validation was to compare the calcu-
lated dose distribution to itself. To simulate 
the fi lm-recorded dose distribution we had to 
rewrite the original fl uence in PTW fi le for-
mat. It was done with the help of commercial 
software (Matlab). Validation of portal signals 
verifi cation was easier to perform, because the 
predicted and acquired images were exported 
from TPS in the same fi le format.
When simulating portal-acquired images ver-
ifi cation we always achieved 100% agreement. 
On the other hand, when verifying the fi lm-sim-
ulated signals we observed negligible deviations 
between g = 0 and g = 0.3 probably caused by in-
terpolation and dose value rounding performed 
during the fi le conversion procedure.
In clinical practice we sometimes observe 
that the fi nal results of verifi cation are incor-
rect. First we try to recognize the location of 
the error and precisely describe what kind 
of tissue it refers to. If the deviation between 
the planned and acquired dose is negligible, 
the physicians usually decide to continue the 
treatment. They also sometimes decide to re-
duce the total number of fractions if the dose 
for organs at risk (OAR) is much higher than 
expected. However, if the reduction of the total 
dose is not possible because of the therapeutic 
effect of the treatment, we have to change the 
treatment plan or perform the verifi cation on 
the parallel treatment unit.
RESULTS
Depending on the size of optimized fl uence it is 
sometimes necessary to split the delivery into 
two or three partially overlapping subfi elds 
(multiple carriage group fi elds). Performing 
Fig. 6. Results of gamma verifi cation: a) g-image, b) cumulative 
histogram, c) differential histogram
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Table 1. Average results of gamma verifi cation obtained for different tumour location
gamma analysis for multiple carriage group 
fi elds we have observed that the radiation 
leakage has an important contribution to the 
effectively accumulated dose, especially in 
the region of the overlapping part of the fi eld, 
and this way can induce signifi cant errors. We 
have performed the g-examination for single 
carriage group fi elds and multiple carriage 
group fi elds separately. Our investigation 
shows that the deviations between the calcu-
lated dose and the dose absorbed by the tissue 
take place more frequently for multiple car-
riage group fi elds, but the level of divergences 
is lower (Fig. 7). The fi elds furthermore have 
been classifi ed depending on the tumour lo-
cation. Table I presents average results ob-
tained for each class. One can conclude that 
the best agreement between the calculated 
and achieved dose distribution is observed for 
brain or prostate locations. Only about 14% 
and 13.1% of the total fi eld area respectively 
do not pass the criteria of correctness.
The results obtained for H&N tumours are 
worse and the corresponding parameter is 
equal to 17.2% in this case.
Fig. 8 presents an example of cumulative 
-histograms obtained for the same therapeu-
tic fi eld with the help of two different meth-
ods of acquisition: fi lm dosimetry and portal 
dosimetry. We have observed that usually the 
results of gamma evaluation when portalac-
quired images are combined with predicted 
portal images are considerably better than if 
the dose recorded on fi lm is compared to the 
calculated one. The fi eld area corresponding 
to the g-value from the range of 0.8–1.2 is as 
much as 10% smaller for portal dosimetry, al-
though the typical deviation is about 4%.
Unfortunately, comparison of the results of 
verifi cation performed by commercial soft-
ware (Eclipse 7.3) and GammaEval is only 
available using g-images because histograms 
are not created by the treatment planning sys-
Fig. 7. The average results of gamma verifi cation 
obtained for single carriage group fi elds and multiple car-
riage group fi elds
tem. Furthermore, it was also not possible to 
compare results for multiple carriage groups: 
Eclipse verifi es each subfi eld separately, be-
cause the portal-acquired images are always 
saved when the beam-off signal occurs.
DISCUSSION
The interpretation of the results is strongly re-
lated to all circumstances of the verifi cation 
procedure: method of image acquisition, signal 
resolution, calculation parameters, and others. 
When calculating g-value according to Eq. 1 
both DTA and DD can be chosen arbitrarily. 
Choosing different values than proposed, one 
can achieve a different value of γ(rc, rm) , and 
furthermore the new pass-fail criteria should 
be defi ned. However, it does not change the 
concept of the gamma algorithm. The tool we 
have created allows one to perform calcula-
tions for any value of DTA and DD, which can 
be chosen arbitrarily by the user.
Location Number of fi elds Field area with g ≤ 1% Stnd. Deviation
Head & Neck 308 17.2 4.8
Brain 150 14 3.9
Prostate 25 13.1 3.5
other 40 15.1 5.3
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Interpretation of gamma value also depends 
on the understanding of Eq. 1. The DD param-
eter may be interpreted differently in the al-
gorithm: in our algorithm its value is related 
to the calculated local dose D(rc) (or local val-
ue of predicted portal image for portal dosim-
etry) and the equation should be preferably 
presented in a much more appropriate form:
 (rc)γ(rc, rm) = 
 rc, rm 2
DTA2
D(rm)-D(rc) 2
ΔD2xD     2+
(2)
The consequence of verifi cation with glob-
ally calculated DD (traditional interpretation 
of gamma algorithm) is an identical accept-
able deviation of all rm , the same for low and 
high expected dose. In this case the dose de-
viation comparable with measured dose
D(rm), for example DD =3.3 cGy, would be ac-
cepted for both D(rm) = 1.0 Gy (3.3% devia-
tion) and D(rm) = 0.1 Gy (33% deviation).
It is essential to emphasize that normaliza-
tion of calculated and recorded dose matrixes 
must be performed inside regions of homoge-
neous dose. We have observed discrepancies if 
the normalization point was set at dose gradi-
ents and/or below the space between adjacent 
leaves of the collimator. Typically, in the case 
of standard 3D CRT, the dose distributions 
were normalized on the beam axis. In the case 
of IMRT verifi cation this procedure may lead 
to overestimation of overall error, especially 
if the signal is at high resolution, because the 
beam axis is always located between central 
leaves of the MLC. To be independent of this 
“normalization effect” we perform calcula-
tions several times, the coordinates of the 
normalization point changing bit by bit with 
a fi xed step. This way the random results are 
eliminated and as a fi nal result of verifi cation 
we take the best g-histogram.
As reported, the results obtained when por-
tal dosimetry is in operation usually look bet-
ter in comparison with fi lm dosimetry. There 
are at least two different reasons for this.
The fi rst one is much better resolution of 
the acquired signal in the case of fi lm dosim-
etry, which allows one to see even point or thin 
line errors (caused for example by the tongue-
and-groove effect).
It is in fact limited only by the fi lm struc-
ture and digitizer technical capacities. On the 
Fig. 8. Results of verifi cation performed with the help of Gam-
maEval for two different methods of acquisition: red line – fi lm, 
blue line – portal dosimetry
Fig. 9. The cross-examination of DRR and g-image (concept) a) 
the fusion of DRR and dose image, b) the fusion of DRR and im-
age, c) 3D-view
other hand, fi lm dosimetry requires a lot of 
work and demands high precision, especially 
when the fi lm is being processed (developer 
temperature, reagents concentration, dura-
tion of developing procedure). If the calibra-
tion and fi lm processing conditions are differ-
ent, the results of gamma verifi cation become 
worse.
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CONCLUSIONS
We believe that the gamma evaluation meth-
od is a reliable and effective instrument for 
IMRT treatment verifi cation. It makes pos-
sible the qualitative and quantitative monitor-
ing of treatment. The procedure discussed in 
this paper can be performed on each treatment 
unit, even if portal dosimetry is not available. 
The key to proper interpretation of results is 
understanding of some critical algorithm pa-
rameters. We have proposed measures which 
eliminate the disadvantage of the normal-
ization effect. However, the only reliable ap-
proach seems to be absolute dose comparison.
We have observed that sometimes the quan-
titative outcomes of the analysis are not ef-
fi cient and may suggest wrong conclusions. 
If the g-histogram is worse than the average 
result, we propose performing cross-examina-
tion of the g-image with DRR, which is shown 
in Fig. 9. The fusion of images is especially 
suggested for multiple carriage group fi elds 
and very small fi elds. We are currently in-
vestigating the procedure for precise location 
and considering the irregularities in dose ac-
cumulated regularly by the target and/or or-
gans at risk while the proper IMRT treatment 
is performed. We are also planning to perform 
some additional tests which will give us more 
knowledge about differences between single 
carriage group and multiple carriage group 
fi elds execution and their infl uence on local 
dose delivery.
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